Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lurasidone 20 mg
DRUG
3 trials
Sponsors
Sumitomo Pharma America, Inc.
Conditions
Major Depressive Disorder
Schizophrenia
Phase 2
Safety and Tolerability Study of Drug to Treat Schizophrenia
Completed
NCT00044005
Sumitomo Pharma America, Inc.
Schizophrenia
Start: 2002-09-30
End: 2003-11-30
Updated: 2014-04-17
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
Completed
NCT00044044
Sumitomo Pharma America, Inc.
Schizophrenia
Start: 2002-07-31
End: 2003-05-31
Updated: 2014-04-17
Phase 3
Major Depressive Disorder With Mixed Features
Withdrawn
NCT01423240
Sumitomo Pharma America, Inc.
Major Depressive Disorder
Start: 2012-01-31
End: 2012-12-31
Updated: 2012-12-13
Related Papers
Assessment of Negative Symptoms in Clinical Trials of Acute Schizophrenia: Test of a Novel Enrichment Strategy
Schizophrenia Bulletin Open
2022-01-01
8 citations